PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $23,934,000 | -0.8% | 7,598,131 | -8.4% | 0.02% | +14.3% |
Q2 2020 | $24,136,000 | +4.1% | 8,294,249 | +0.9% | 0.02% | -8.7% |
Q1 2020 | $23,190,000 | -12.5% | 8,223,531 | +0.6% | 0.02% | +15.0% |
Q4 2019 | $26,514,000 | +31.1% | 8,170,631 | -12.7% | 0.02% | +17.6% |
Q3 2019 | $20,227,000 | -28.6% | 9,364,285 | +3.8% | 0.02% | -32.0% |
Q2 2019 | $28,326,000 | -20.9% | 9,021,082 | -6.3% | 0.02% | -24.2% |
Q1 2019 | $35,818,000 | +36.1% | 9,628,500 | +6.1% | 0.03% | +13.8% |
Q4 2018 | $26,319,000 | +9.1% | 9,075,500 | -1.1% | 0.03% | +16.0% |
Q3 2018 | $24,127,000 | -52.7% | 9,173,954 | -52.6% | 0.02% | -10.7% |
Q2 2018 | $51,039,000 | +79.9% | 19,337,208 | +100.4% | 0.03% | -9.7% |
Q1 2018 | $28,368,000 | +0.7% | 9,648,854 | -6.2% | 0.03% | 0.0% |
Q4 2017 | $28,179,000 | -25.3% | 10,284,454 | -7.6% | 0.03% | -29.5% |
Q3 2017 | $37,737,000 | +42.7% | 11,131,786 | +4.0% | 0.04% | +29.4% |
Q2 2017 | $26,440,000 | -3.2% | 10,704,400 | -11.1% | 0.03% | -10.5% |
Q1 2017 | $27,323,000 | +0.1% | 12,036,754 | -6.5% | 0.04% | -11.6% |
Q4 2016 | $27,296,000 | -39.5% | 12,875,700 | -4.4% | 0.04% | -46.2% |
Q3 2016 | $45,134,000 | +14.4% | 13,472,854 | +7.2% | 0.08% | +6.7% |
Q2 2016 | $39,456,000 | -6.9% | 12,565,654 | -1.2% | 0.08% | -7.4% |
Q1 2016 | $42,372,000 | +15.7% | 12,724,354 | +23.0% | 0.08% | +1.2% |
Q4 2015 | $36,623,000 | -19.1% | 10,345,559 | +15.0% | 0.08% | -25.9% |
Q3 2015 | $45,251,000 | -39.0% | 8,996,154 | -22.0% | 0.11% | -36.1% |
Q2 2015 | $74,156,000 | -11.9% | 11,532,754 | -3.7% | 0.17% | -5.6% |
Q1 2015 | $84,220,000 | -7.2% | 11,971,554 | +1.7% | 0.18% | -18.3% |
Q4 2014 | $90,754,000 | -11.6% | 11,771,000 | -14.4% | 0.22% | -22.1% |
Q3 2014 | $102,682,000 | -17.7% | 13,745,892 | +6.6% | 0.28% | -3.4% |
Q2 2014 | $124,841,000 | +26.7% | 12,896,754 | +8.7% | 0.29% | +23.3% |
Q1 2014 | $98,550,000 | +0.1% | 11,859,184 | +1.7% | 0.24% | 0.0% |
Q4 2013 | $98,456,000 | +6.6% | 11,665,354 | +0.6% | 0.24% | +5.4% |
Q3 2013 | $92,388,000 | -0.2% | 11,591,954 | -3.3% | 0.22% | -7.8% |
Q2 2013 | $92,552,000 | – | 11,988,554 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KESTREL INVESTMENT MANAGEMENT CORP | 1,585,500 | $3,710,000 | 1.36% |
SMH CAPITAL ADVISORS INC | 83,369 | $195,000 | 0.32% |
West Family Investments, Inc. | 338,141 | $791,000 | 0.20% |
Matarin Capital Management, LLC | 927,289 | $2,169,856,000 | 0.16% |
ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $33,000 | 0.12% |
Alambic Investment Management, L.P. | 163,200 | $382,000 | 0.10% |
KENNEDY CAPITAL MANAGEMENT LLC | 1,760,376 | $4,119,000 | 0.08% |
Connor, Clark & Lunn Investment Management Ltd. | 5,677,647 | $13,286,000 | 0.08% |
Zebra Capital Management LLC | 67,892 | $159,000 | 0.07% |
Fortis Advisors, LLC | 45,602 | $107,000 | 0.06% |